OTC Markets OTCPK - Delayed Quote USD
Propanc Biopharma, Inc. (PPCB)
6.46
+0.96
+(17.45%)
At close: April 23 at 4:00:00 PM EDT
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Cash Flow
-604.56
-935.12
-1,105.25
-1,436.30
-1,145.26
Financing Cash Flow
613.13
941.89
1,113.72
1,490.79
1,058.04
End Cash Position
80.22
21.09
10.05
4.07
2.26
Interest Paid Supplemental Data
20.90
9.49
2.88
2.39
13.62
Issuance of Capital Stock
68.40
23.06
24.71
99.29
--
Issuance of Debt
688.48
1,061.75
590.25
766.50
325
Repayment of Debt
-98.40
-142.91
--
--
-43
Free Cash Flow
-604.56
-935.12
-1,105.25
-1,436.30
-1,145.26
6/30/2021 - 1/7/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ENDV Endonovo Therapeutics, Inc.
0.0002
0.00%
KTTA Pasithea Therapeutics Corp.
1.6300
+5.84%
KZIA Kazia Therapeutics Limited
3.3250
-3.76%
SONN Sonnet BioTherapeutics Holdings, Inc.
1.4200
+9.23%
GBLX GB Sciences, Inc.
0.0002
0.00%
CDT Conduit Pharmaceuticals Inc.
0.5565
-4.22%
VRTX.MX Vertex Pharmaceuticals Incorporated
9,360.00
0.00%
ARTH Arch Therapeutics, Inc.
0.1608
0.00%
MTEM Molecular Templates, Inc.
0.0001
0.00%
RADX Radiopharm Theranostics Limited
4.0500
-3.34%